Balverde, Judy Ann D.
HRN: 14-39-40 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2025
AMPICILLIN 1GM (VIAL)
12/20/2025
12/21/2025
IV
2gms
Q6hrs Until Delivery
PROM X 6 Hrs
Checking Initial Appropriateness
12/21/2025
CO-AMOXICLAV 625MG (TAB)
12/21/2025
12/28/2025
ORAL
500mg
BID
S/P NSD With Repair; PROM
Checking Initial Appropriateness